0 556

Cited 0 times in

Whole-breast US following mammography and breast MRI in newly diagnosed breast cancer patients: can it be more than just a guidance tool for biopsy?

Authors
 Y.J. Park  ;  M.J. Kim  ;  H.J. Moon  ;  E.-K. Kim  ;  J.H. Yoon 
Citation
 CLINICAL RADIOLOGY, Vol.72(5) : 4251-4257, 2017 
Journal Title
CLINICAL RADIOLOGY
ISSN
 0009-9260 
Issue Date
2017
MeSH
Adult ; Aged ; Biopsy ; Breast/diagnostic imaging ; Breast/pathology ; Breast Neoplasms/diagnostic imaging* ; Breast Neoplasms/pathology ; Female ; Humans ; Magnetic Resonance Imaging/methods* ; Mammography/methods ; Middle Aged ; Predictive Value of Tests ; Retrospective Studies ; Risk Factors ; Sensitivity and Specificity ; Ultrasonography, Mammary/methods*
Abstract
AIM: To evaluate the role of ultrasound (US) following magnetic resonance imaging (MRI) and mammography in patients with newly diagnosed breast cancers by assessing the additional cancer detection rate of US.

MATERIAL AND METHODS: Two hundred and twenty-five women who had undergone 225 MRI examinations followed by US were included. An US-detected additional cancer was defined as a lesion detected using breast US that had not been detected by MRI, and which was shown to be malignant at histopathology. The rate of additional cancer detection, incidence of additional malignancies, positive predictive value (PPV), and false-positive (FP) rate were analysed. Factors associated with an increase in the additional cancer detection rate were analysed.

RESULTS: The additional cancer detection rate was 0% (0/225) for the ipsilateral breast and 0.9% (2/225) for the contralateral breast, and the PPVs were 0% (0/5) and 100% (2/2), respectively. The overall TP:FP ratio was 0.4 (2:5). The additional cancer detection rate was higher for cases with moderate and severe background parenchymal enhancement than cases with minimal and mild background parenchymal enhancement (p=0.003). The additional cancer detection rate for cases with moderate and severe background parenchymal enhancement was 5.7% (2/35) for the contralateral breast (p=0.003).

CONCLUSION: Preoperative breast US following MRI and mammography can help clinicians screen for contralateral cancers with an additional detection rate of 0.9%. Moreover, whole-breast US might be a useful contralateral screening modality in cases with moderate or marked parenchymal enhancement on breast MRI.
Full Text
http://www.sciencedirect.com/science/article/pii/S0009926016303488
DOI
10.1016/j.crad.2016.09.003
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers
Yonsei Authors
Kim, Min Jung(김민정) ORCID logo https://orcid.org/0000-0003-4949-1237
Kim, Eun-Kyung(김은경) ORCID logo https://orcid.org/0000-0002-3368-5013
Moon, Hee Jung(문희정) ORCID logo https://orcid.org/0000-0002-5643-5885
Yoon, Jung Hyun(윤정현) ORCID logo https://orcid.org/0000-0002-2100-3513
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/154638
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links